Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat

Jonathan R. Rumble, Radko Komers, Mark E. Cooper

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objective. To determine the roles played by kinins/nitric oxide and angiotensin II in the antitrophic effects of angiotensin converting enzyme inhibitors on mesenteric arteries after 3 weeks of streptozotocin diabetes by using blockers both of the angiotensin II AT1 receptor and of the bradykinin B2 receptor. Design. Male diabetic Wistar rats were randomly allocated to receive no treatment, the angiotensin converting enzyme inhibitors perindopril or ramipril, the AT1 receptor blocker ZD7155, the bradykinin B2 receptor blocker Hoe140, the nitric oxide synthase inhibitor N(G)-nitro-L-arginine-methyl ester, concomitant administration of perindopril plus subcutaneous Hoe140, perindopril plus N(G)-nitro-L-arginine, or ramipril plus Hoe140 (Hoe140 administered via an Alzet mini-osmotic pump). Methods. After 3 weeks, the rats were killed, their blood collected and their mesenteric vessels removed. The mesenteric vascular weight was measured and the media wall:lumen area ratio was assessed using quantitative histomorphometric techniques. Results. Diabetes was associated with an increase in mesenteric weight and media wall:lumen area ratio. The angiotensin converting enzyme inhibitors, perindopril and ramipril, and the AT1 receptor antagonist ZD7155 reduced blood pressure and attenuated vascular weight and media wall:lumen area ratio. Concomitant administration of an angiotensin converting enzyme inhibitor with the kinin antagonist Hoe140, administered either subcutaneously or via a mini-osmotic pump, or of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine attenuated the effect of the angiotensin converting enzyme inhibitor on the mesenteric vascular weight and wall:lumen area ratios. Treatment with Hoe140 or N(G)-nitro-L-arginine alone affected none of these parameters. Conclusion. The antitrophic effect of angiotensin converting enzyme inhibitors on diabetic mesenteric arteries is mediated by inhibition of angiotensin II and by actions on the kinin-nitric oxide pathway.

Original languageEnglish (US)
Pages (from-to)601-607
Number of pages7
JournalJournal of Hypertension
Volume14
Issue number5
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

Kinins
Angiotensin-Converting Enzyme Inhibitors
Perindopril
Hypertrophy
Blood Vessels
Nitric Oxide
Ramipril
Arginine
Weights and Measures
Mesenteric Arteries
Nitric Oxide Synthase
Angiotensin II
Bradykinin B2 Receptors
Tunica Media
Angiotensin Type 1 Receptor
Angiotensin Receptors
Experimental Diabetes Mellitus
NG-Nitroarginine Methyl Ester
icatibant
Wistar Rats

Keywords

  • Angiotensin converting enzyme inhibitors
  • Angiotensin II
  • Kinins
  • Mesenteric vessels
  • Nitric oxide
  • Vascular hypertrophy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat. / Rumble, Jonathan R.; Komers, Radko; Cooper, Mark E.

In: Journal of Hypertension, Vol. 14, No. 5, 1996, p. 601-607.

Research output: Contribution to journalArticle

@article{72b8de0d8168404a81fd6ef25f2ba52b,
title = "Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat",
abstract = "Objective. To determine the roles played by kinins/nitric oxide and angiotensin II in the antitrophic effects of angiotensin converting enzyme inhibitors on mesenteric arteries after 3 weeks of streptozotocin diabetes by using blockers both of the angiotensin II AT1 receptor and of the bradykinin B2 receptor. Design. Male diabetic Wistar rats were randomly allocated to receive no treatment, the angiotensin converting enzyme inhibitors perindopril or ramipril, the AT1 receptor blocker ZD7155, the bradykinin B2 receptor blocker Hoe140, the nitric oxide synthase inhibitor N(G)-nitro-L-arginine-methyl ester, concomitant administration of perindopril plus subcutaneous Hoe140, perindopril plus N(G)-nitro-L-arginine, or ramipril plus Hoe140 (Hoe140 administered via an Alzet mini-osmotic pump). Methods. After 3 weeks, the rats were killed, their blood collected and their mesenteric vessels removed. The mesenteric vascular weight was measured and the media wall:lumen area ratio was assessed using quantitative histomorphometric techniques. Results. Diabetes was associated with an increase in mesenteric weight and media wall:lumen area ratio. The angiotensin converting enzyme inhibitors, perindopril and ramipril, and the AT1 receptor antagonist ZD7155 reduced blood pressure and attenuated vascular weight and media wall:lumen area ratio. Concomitant administration of an angiotensin converting enzyme inhibitor with the kinin antagonist Hoe140, administered either subcutaneously or via a mini-osmotic pump, or of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine attenuated the effect of the angiotensin converting enzyme inhibitor on the mesenteric vascular weight and wall:lumen area ratios. Treatment with Hoe140 or N(G)-nitro-L-arginine alone affected none of these parameters. Conclusion. The antitrophic effect of angiotensin converting enzyme inhibitors on diabetic mesenteric arteries is mediated by inhibition of angiotensin II and by actions on the kinin-nitric oxide pathway.",
keywords = "Angiotensin converting enzyme inhibitors, Angiotensin II, Kinins, Mesenteric vessels, Nitric oxide, Vascular hypertrophy",
author = "Rumble, {Jonathan R.} and Radko Komers and Cooper, {Mark E.}",
year = "1996",
doi = "10.1097/00004872-199605000-00009",
language = "English (US)",
volume = "14",
pages = "601--607",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat

AU - Rumble, Jonathan R.

AU - Komers, Radko

AU - Cooper, Mark E.

PY - 1996

Y1 - 1996

N2 - Objective. To determine the roles played by kinins/nitric oxide and angiotensin II in the antitrophic effects of angiotensin converting enzyme inhibitors on mesenteric arteries after 3 weeks of streptozotocin diabetes by using blockers both of the angiotensin II AT1 receptor and of the bradykinin B2 receptor. Design. Male diabetic Wistar rats were randomly allocated to receive no treatment, the angiotensin converting enzyme inhibitors perindopril or ramipril, the AT1 receptor blocker ZD7155, the bradykinin B2 receptor blocker Hoe140, the nitric oxide synthase inhibitor N(G)-nitro-L-arginine-methyl ester, concomitant administration of perindopril plus subcutaneous Hoe140, perindopril plus N(G)-nitro-L-arginine, or ramipril plus Hoe140 (Hoe140 administered via an Alzet mini-osmotic pump). Methods. After 3 weeks, the rats were killed, their blood collected and their mesenteric vessels removed. The mesenteric vascular weight was measured and the media wall:lumen area ratio was assessed using quantitative histomorphometric techniques. Results. Diabetes was associated with an increase in mesenteric weight and media wall:lumen area ratio. The angiotensin converting enzyme inhibitors, perindopril and ramipril, and the AT1 receptor antagonist ZD7155 reduced blood pressure and attenuated vascular weight and media wall:lumen area ratio. Concomitant administration of an angiotensin converting enzyme inhibitor with the kinin antagonist Hoe140, administered either subcutaneously or via a mini-osmotic pump, or of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine attenuated the effect of the angiotensin converting enzyme inhibitor on the mesenteric vascular weight and wall:lumen area ratios. Treatment with Hoe140 or N(G)-nitro-L-arginine alone affected none of these parameters. Conclusion. The antitrophic effect of angiotensin converting enzyme inhibitors on diabetic mesenteric arteries is mediated by inhibition of angiotensin II and by actions on the kinin-nitric oxide pathway.

AB - Objective. To determine the roles played by kinins/nitric oxide and angiotensin II in the antitrophic effects of angiotensin converting enzyme inhibitors on mesenteric arteries after 3 weeks of streptozotocin diabetes by using blockers both of the angiotensin II AT1 receptor and of the bradykinin B2 receptor. Design. Male diabetic Wistar rats were randomly allocated to receive no treatment, the angiotensin converting enzyme inhibitors perindopril or ramipril, the AT1 receptor blocker ZD7155, the bradykinin B2 receptor blocker Hoe140, the nitric oxide synthase inhibitor N(G)-nitro-L-arginine-methyl ester, concomitant administration of perindopril plus subcutaneous Hoe140, perindopril plus N(G)-nitro-L-arginine, or ramipril plus Hoe140 (Hoe140 administered via an Alzet mini-osmotic pump). Methods. After 3 weeks, the rats were killed, their blood collected and their mesenteric vessels removed. The mesenteric vascular weight was measured and the media wall:lumen area ratio was assessed using quantitative histomorphometric techniques. Results. Diabetes was associated with an increase in mesenteric weight and media wall:lumen area ratio. The angiotensin converting enzyme inhibitors, perindopril and ramipril, and the AT1 receptor antagonist ZD7155 reduced blood pressure and attenuated vascular weight and media wall:lumen area ratio. Concomitant administration of an angiotensin converting enzyme inhibitor with the kinin antagonist Hoe140, administered either subcutaneously or via a mini-osmotic pump, or of the nitric oxide synthase inhibitor N(G)-nitro-L-arginine attenuated the effect of the angiotensin converting enzyme inhibitor on the mesenteric vascular weight and wall:lumen area ratios. Treatment with Hoe140 or N(G)-nitro-L-arginine alone affected none of these parameters. Conclusion. The antitrophic effect of angiotensin converting enzyme inhibitors on diabetic mesenteric arteries is mediated by inhibition of angiotensin II and by actions on the kinin-nitric oxide pathway.

KW - Angiotensin converting enzyme inhibitors

KW - Angiotensin II

KW - Kinins

KW - Mesenteric vessels

KW - Nitric oxide

KW - Vascular hypertrophy

UR - http://www.scopus.com/inward/record.url?scp=0029973752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029973752&partnerID=8YFLogxK

U2 - 10.1097/00004872-199605000-00009

DO - 10.1097/00004872-199605000-00009

M3 - Article

C2 - 8762203

AN - SCOPUS:0029973752

VL - 14

SP - 601

EP - 607

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 5

ER -